Marengo Therapeutics News and Activities

View the org chart displaying its 16 main executives

Most searched biographies at Marengo Therapeutics

• Zhen Su, Chief Executive Officer and Director
• Anna Batarina, Board Member
• Raj Chopra, Director

Popular executive movements at Marengo Therapeutics

• Svetlana Makhni, Chief Financial Officer, has left the company  (posted on April 17 2026).
• Andrew Bayliffe, Chief Scientific Officer and Director, has left the company  (posted on October 1 2025).

Create your alert
to follow the executive moves at Marengo Therapeutics.

Marengo Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Marengo Therapeutics

• Ipsen extends Marengo partnership with $1.2bn T cell research deal - Pharmaceutical Technology
• Ipsen and Marengo expand oncology research partnership in deal worth $1.2bn - PMLiVE
• Ipsen’s latest R&D alliance brings novel T cell-activating drugs for cancer - MedCity News
• https://marengotx.com/wp-content/uploads/2022/09/Marengo-IND-CRADA-Press-Release-2022.09.14_FINAL-CLEAN.pdf
• News & Investors – Marengo Therapeutics
• News & Investors – Marengo Therapeutics
• View more press releases Close

Social media about Marengo Therapeutics

• Marengo Therapeutics on Wikipedia, Google News & Yahoo Finance
• Marengo Therapeutics on LinkedIn, X (Twitter) & YouTube